ICAM1 and glioma: Treatment of human umbilical vein ECs (HUVECs) with CM from oHSV-infected glioma cells increased expression of EC activation surface receptors: CD54 (ICAM1), CD106 (VCAM1), and CD62P (P-selectin) (Figure 1A).